Sight Sciences Stock

sightsciences.comHealthcareFunding to Date: $180MM

Sight Sciences is a medical devices company developing products that target the underlying causes of the world's most prevalent eye diseases.

Register for Details

For more details on financing and valuation for Sight Sciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Paul Badawi
Co-Founder, President, Chief Executive Officer & Board Member
Jesse Selnick
Chief Financial Officer
David Badawi MD
Co-Founder, Chief Technology Officer & Board Member
Shawn O'Neil
Chief Commercial Officer
Stephen Thau
Secretary
Daniel O'Keeffe
Vice President, Research & Development
Reay Brown
Chief Medical Officer

Board Members

Carter Meyer JD
Scientific Health Development
David Badawi MD
Mack Hicks
Hicks Equity Partners
Paul Badawi
Tommy Hicks
Valeska Schroeder Ph.D

Other companies like Sight Sciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$453MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$263MM

News

Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepr
Sight Sciences, a medical device company focused on ophthalmology and optometry, glaucoma and dry eye disease, closed a $31m in Series D financing